Release Date: 27/10/15 17:24 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 49.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%